Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Medivir to participate at the Kempen Life Sciences Conference

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will participate at the Kempen Life Sciences Conference, April 21.   More information about the event is available at the organizer’s website: https://www.kempen.com/en/securities/events/life-sciences-conference     For additional information, please contact Magnus Christensen, CFO Telephone: +46 8 5468 3100 E-mail: magnus.christensen@medivir.com                Medivir in brief Medivir develops innovative drugs with a focus on cancer where the unmet

Winning more bids: Free webinar for bid professionals

GLOBAL software provider, Ideagen Plc, has partnered with the Association of Proposal Management Professionals (APMP) to host a free webinar for bid professionals, with a focus on building intelligence and formulating the winning strategy for bids.The webinar, titled The Winning Formula: Eliminate Frustration and Win More Bids, is taking place on Tuesday, April 26, between 11:00 and 12:00 EDT, and will feature an impressive line-up of speakers who will discuss their experiences and insights on improving bid efficiency. Some of the key subject areas of the webinar will be; building

Notice of annual general meeting of Mekonomen 2022

Welcome to the annual general meeting of Mekonomen 2022 The shareholders of Mekonomen Aktiebolag are hereby invited to attend the annual general meeting to be held on Friday, 20 May 2022 at 10.00 CET at Bygget, Norrlandsgatan 11, in Stockholm. Registration for the AGM opens at 09.00 CET. The board of Mekonomen has decided that shareholders shall be able to exercise their voting rights at the annual general meeting also by postal voting in accordance with the regulations in Mekonomen’s article of association. Right to participate, notification, proxies etc. Shareholders who wish

Share repurchase update from Catena Media

From 1 March 2022 to 14 April 2022, Catena Media plc repurchased 1,973,000 of its ordinary shares for SEK 90.6 million as part of a share buyback programme initiated during the third quarter of 2021 to promote more efficient capital usage by returning excess capital to shareholders. All repurchases were executed on Nasdaq Stockholm by Carnegie Investment Bank on behalf of Catena Media. The volume-weighted average price of these transactions during the period was SEK 45.94 per share. Following the repurchases and as of 14 April 2022, Catena Media holds 4,295,510, or 5.6 percent, of its

Nokian Tyres will publish its Interim Report January−March 2022 on April 27, 2022

Nokian Tyres plc Press Release April 19, 2022 at 3:00 p.m.   Nokian Tyres will publish its Interim Report January−March 2022 on April 27, 2022 approximately at 2:00 p.m. EET. After publication, the release and presentation material will be available on the company's website at www.nokiantyres.com/company/investors/.   Conference call   A conference call for investors, analysts and media will be held on April 27 at 3:00 p.m. EET. In the call, President and CEO Jukka Moisio and CFO Teemu Kangas-Kärki will present the financial results.   To participate, please dial in

Aker Solutions ASA: Invitation to Presentation of First-Quarter Results for 2022

April 19, 2022 - Aker Solutions will publish its first-quarter results for 2022 on Tuesday, May 3, at 07:00 CEST. A live audiocast will take place the same day at 09:00 CEST.Please note that the results will be presented by audiocast only. To join the live audiocast, go to https://www.akersolutions.com/audiocast There will be a Q&A session at the end of the presentation. Written questions can be submitted through the audiocast solution or sent in advance to communications@akersolutions.com After the live presentation there will be an opportunity for the press to do individual

Charlotta Gauffin PhD is the new Chief Scientific Officer at Dicot

Press release: Uppsala, April 19, 2022. Charlotta Gauffin PhD has been hired as Chief Scientific Officer at Dicot starting July 11 with the task of leading the development of the company's potency drug. Dr. Gauffin has over 20 years of experience in drug development, of which more than 15 years in clinical development.The Uppsala based pharmaceutical company Dicot has previously announced that it intends to broaden and strengthen the management for the next phase where focus will be on clinical studies, business development, and partnerships with international pharmaceutical companies. An

Anora Group Plc: Notice of the Annual General Meeting 2022

Anora Group Plc   Stock Exchange Release   19 April 2022 at 2:35 pm EET Anora Group Plc: Notice of the Annual General Meeting 2022 Notice is given to the shareholders of Anora Group Plc of the Annual General Meeting to be held on Wednesday, 11 May 2022 at 1:00 p.m. at Anora’s head office at the address Kaapeliaukio 1, FI-00180, Helsinki, Finland. The shareholders of the company and their proxy representatives can only participate in the meeting and exercise their shareholder’s rights by voting in advance as well as by submitting counterproposals and asking questions in advance. It

Notification according to Chapter 9, Section 10 of the Securities Markets Act of change in holdings in YIT Corporation shares

YIT Corporation Stock exchange release 19 April 2022 at 2:30 p.m.Notification according to Chapter 9, Section 10 of the Securities Markets Act of change in holdings in YIT Corporation shares YIT Corporation has on 19 April 2022 received an announcement under Chapter 9, Section 5 and 6 of the Securities Markets Act, according to which the holding of Virala Oy Ab has exceeded the threshold of 15 per cent. According to the announcement, the holding had exceeded the threshold on 14 April 2022. According to the announcement, the total number of YIT shares owned directly or through

Anora’s Annual Report 2021 and Remuneration Report 2021 have been published

Anora Group Plc Stock Exchange Release 19 April 2022 at 2:30 pm EET Anora’s Annual Report 2021 and Remuneration Report 2021 have been published Anora Group Plc has today published its Annual Report 2021. The Annual Report consists of the Business Overview, the Report by the Board of Directors, the Non-financial Statement, the Disclosure according to the EU Taxonomy Regulation, the Financial Statements with notes, the Corporate Governance Statement, the Remuneration Report, and the Sustainability Report for 2021. The Annual Report is published in Finnish and English. The complete

BLAST Premier Spring Final set to be hosted at Altice Arena in Lisbon

The BLAST Premier Spring Final (15-19 June) will take place at Altice Arena in Lisbon - the biggest indoor arena in Portugal and one of the biggest in Europe.Eight of the world’s leading teams will head to Lisbon in June to compete for a prize pool of $425,000/€392,000 and a place in the highly-anticipated World \Final in December.  Six teams have already confirmed their place at the Spring Final, including newly ranked world number one team FaZe Clan, who are coming into the event in fine form off the back of winning IEM Katowice in February and claiming first place at this month’s ESL

Storskogen acquires Danboring

Storskogen has entered an agreement to acquire 90.1 percent of the shares in Danboring A/S (”Danboring”). The company specialises in trenchless pipe installations in Denmark, Norway, Sweden, and Germany. Danboring reported an EBITA of DKK 28 million during 2021. The acquisition will add to Storskogen’s other companies operating within trenchless technologies.Danboring was founded in 1997 and is headquartered in Kjellerup, Denmark, with around 35 employees. The company offers a wide range of services in trenchless technologies, including directional drilling for water, sewage, electrical

Elkem ASA - Disclosure of voting rights at the annual general meeting

Oslo, 19 April 2022 In connection with the annual general meeting of Elkem ASA, to be held on 27 April 2022, the deputy chair of the board of directors, Mr. Dag J. Opedal, has received a proxy without voting instructions to vote for the 338,338,536 shares held by Bluestar Elkem International Co., Ltd. S.A, representing 52.91% of the shares and votes in Elkem ASA. In addition, the deputy chair has at the date hereof received proxies without voting instructions for 101,655 shares from other shareholders, representing 0.02% of the shares and votes. The proxies received are only valid for

Visma to support Team Jumbo-Visma in its search for The Next Top Mechanic

Visma has been proud title sponsor of Team Jumbo-Visma since 2019, and are now supporting the team in a first-of-its-kind recruitment campaign.Visma supports Team-Jumbo-Visma by providing technology that solves complex challenges and optimises performance. Whether helping the team run financial processes, sign contracts, manage business leads and contacts, or analyse data for insights, we help Team Jumbo-Visma perform their best through excellent cloud software. Now we are using our software and business expertise to actively support Team Jumbo-Visma in their search for their Next Top

Eklund Foundation for Odontological Research and Education welcomes applications 1-31 May

Researchers within dentistry will soon be able to apply for grants of up to €250,000, which is the total sum allocated by the Eklund Foundation in 2022. The application portal will be open during May for the seventh year running, welcoming applicants from all parts of the world in all fields of dentistry.Both experimental and clinical studies within all fields of dentistry are accepted, but the foundation will prioritise projects that can be related to periodontology, implantology, or cariology. Researchers may apply for funding for a project in its entirety or for part of a project. The

Notice of the 2022 Annual General Meeting of Tobii

Tobii AB (publ) hereby summons to the annual general meeting on Wednesday 25 May 2022. The annual general meeting will be carried out through advance voting (postal voting) only pursuant to temporary legislation and Tobii welcomes all shareholders to exercise their voting rights at this annual general meeting through advance voting according to the procedure set out below.   Information on the resolutions passed at the annual general meeting will be published on 25 May 2022, as soon as the result of the voting has been finally confirmed.   Notification of participation

Ove B. Haupberg appointed new CFO in Multiconsult ASA

Multiconsult (Oslo: MULTI) has appointed Ove B. Haupberg new Chief Financial Officer (CFO). Mr Haupberg comes from a position as CFO in Eltel Networks Norway and has extensive financial and management experience from several leading companies. Among others he has served as CFO for OBOS BBL and COOP Norge SA. Ove B. Haupberg hold an MSc. in Business from Norwegian School of Economics (NHH) in Bergen.Mr Haupberg will begin in his new role 1 September 2022. “We are very happy to welcome Ove as the new CFO for Multiconsult and as a valuable addition to the Executive Management Team. With his

Raute Corporation's President and CEO Tapani KIiski leaves his position

RAUTE CORPORATION STOCK EXCHANGE RELEASE 19 APRIL 2022 at 1:00 p.m.RAUTE CORPORATION'S PRESIDENT AND CEO TAPANI KIISKI LEAVES HIS POSITION   Raute Corporation’s President and CEO Tapani Kiiski will leave his position by mutual agreement with the company as of 30 April 2022. Kiiski has been Raute’s President and CEO since March 16, 2004.   “After discussing the company’s next development needs and future growth targets with the CEO, we came to the conclusion that now is the right time for a change. Tapani Kiiski’s significant contribution has helped Raute internationalize and

Invitation to UPM’s webcast and press conference on Q1 2022 Interim Report

(UPM, Helsinki, 19 April 2022 at 13:00 EEST) – UPM will publish its Q1 2022 Interim Report on 26 April 2022 at 09:30-10:00 EEST. After publishing the report will be available on company's website at www.upm.com . A webcast and a conference call for analysts and investors in English language begins at 13:15 EEST. UPM’s financial results will be presented by the President and CEO Jussi Pesonen and CFO Tapio Korpeinen. All participants can view the webcast online at www.upm.com  or through this link 

Thomas Segell appointed new CEO of Nordic Credit Partners

Thomas Segell has been appointed new CEO of Nordic Credit Partners ("NCP"). In this role, Thomas will lead and assume the overall strategic, financial and operational responsibility for the company. He will also manage all regulatory affairs and report to the board of directors. Jakob Eliasson, founder and current CEO of NCP, will continue as CIO with overall responsibility for portfolio management.Thomas joins NCP from hedge fund Nyhavn Capital where he was deputy CEO, COO and served as board member of the Cayman Islands based fund, Nyhavn Global Equity Long Short. Prior to that, he worked

Akobo Minerals receives more assay results

OSLO, 19 April 2022: Akobo Minerals (Euronext Oslo – “AKOBO”), the Scandinavian-based Ethiopian gold exploration and boutique mining company, today announced that it has released a new set of infill drilling assays from its Segele mine development project. The results are intended to allow for an upgrade of the resource classifications in the ongoing resource estimate.   · New infill drilling results including: · 136.5 g/t over 2.3m, including 580g/t over 0.5m · 114.7g/t over 13.1m, including 686g/t over 2.0m · 53.6g/t over 5.2m, including 446g/t over 0.4m · 46.

Hansa Biopharma announces U.S. FDA acceptance of Investigational New Drug (IND) application for Phase 3 study of imlifidase in anti-GBM disease

· Pivotal Phase 3 study to commence in 2022 and is expected to enroll 50 patients across the U.S. and Europe · Scientific advice on protocol obtained from both the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) with the aim of conducting a global study · Clinical Phase 2 data suggests that deactivation of autoantibodies by imlifidase could alter the course of this serious autoimmune disease Lund, Sweden, April 19, 2022. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), pioneer in enzyme technology for rare immunological conditions, today announces

There are no items matching the current filter
There are no more items matching the current filter
Back to top